In 2019, to help meet viral hepatitis targets from the WHO, studies have developed optimal strategies to enable transplantation of HCV-positive organs, assessed the real-world efficacy of salvage therapy for direct-acting antiviral therapy failures in chronic HCV infection and evaluated the risk of hepatocellular carcinoma with current first-line antiviral therapies for chronic HBV infection.

中文翻译：

---

病毒性器官移植和抗病毒治疗的新方法。

在2019年，为了帮助实现WHO的病毒性肝炎目标，研究制定了最佳策略以实现HCV阳性器官的移植，评估了挽救疗法在慢性HCV感染中直接作用抗病毒治疗失败的实际疗效并评估了当前针对慢性HBV感染的一线抗病毒治疗导致肝细胞癌的风险。